This brand name is authorized in Australia, Austria, Croatia, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Italy, Lithuania, Netherlands, Poland, Romania, Singapore, Spain, Turkey, UK.
The drug LORVIQUA contains one active pharmaceutical ingredient (API):
1
|
UNII
OSP71S83EU - LORLATINIB
|
|
Lorlatinib is a selective, adenosine triphosphate (ATP)-competitive inhibitor of ALK and c-ros oncogene 1 (ROS1) tyrosine kinases. |
|
Below package inserts are available for further reading:
| Document | Type | Information Source | |
|---|---|---|---|
| LORVIQUA Film-coated tablet | MPI, EU: SmPC | European Medicines Agency (EU) |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| L01ED05 | L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01E Protein kinase inhibitors → L01ED Anaplastic lymphoma kinase (ALK) inhibitors | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| AU | Pharmaceutical Benefits Scheme | 12091J, 12096P |
| EE | Ravimiamet | 1796092, 1796104, 1816422 |
| ES | Centro de información online de medicamentos de la AEMPS | 1191355001, 1191355002 |
| FI | Lääkealan turvallisuus- ja kehittämiskeskus | 169944, 406435 |
| FR | Base de données publique des médicaments | 63776483, 66586838 |
| GB | Medicines & Healthcare Products Regulatory Agency | 375924, 375929, 386098 |
| HK | Department of Health Drug Office | 66411, 66412 |
| IE | Health Products Regulatory Authority | 88822, 88823 |
| IL | מִשְׂרַד הַבְּרִיאוּת | 8633, 8702 |
| IT | Agenzia del Farmaco | 047942014, 047942026, 047942038 |
| LT | Valstybinė vaistų kontrolės tarnyba | 1087714, 1087715, 1090329 |
| NL | Z-Index G-Standaard, PRK | 198137, 198145 |
| PL | Rejestru Produktów Leczniczych | 100417725, 100417731 |
| RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | W66359001, W66359002, W66360001 |
| SG | Health Sciences Authority | 15830P, 15831P |
| TR | İlaç ve Tıbbi Cihaz Kurumu | 8681308092007, 8681308092014, 8681308092021, 8681308092038, 8681308092045, 8681308092052, 8681308092069 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.